EX-99 2 b74752a1exv99.htm EX-99 FEBRUARY 2009 MONTHLY INSIGHT REPORT EX-99 February 2009 Monthly Insight Report
(IMAGE)
THE CHINA FUND, INC. (CHN)
(IMAGE)
The Martin Currie
Shanghai team
IN BRIEF
         
Net asset value per share
  US$ 16.15  
Market price
  US$ 14.40  
Premium/(discount)
    (10.84 %)
Fund size
  US$ 368.0m  
     
Source:   State Street Bank and Trust Company
                 
At 28 February 2009           US$ returns  
    China Fund NAV     MSCI Golden Dragon*  
    %     %  
One month
    (1.4 )     (1.6 )
Year to date
    (7.1 )     (8.3 )
One year
    (46.5 )     (49.1 )
Three years %pa
    8.2       (5.8 )
     
Past performance is not a guide to future returns.
 
Source:   State Street Bank and Trust Company. NAV performance.
 
* Source for index data: MSCI.
MANAGER’S COMMENTARY
Perhaps February was when the Chinese markets started to de-couple from the West. This is clearly a dangerous thing to say, but the massive market turnover in the A-share market (US$40 billion on one busy day last month) is at least an indication that liquidity and leverage are not the main problems in China. Far from having to bail out its banks (the loan-to-deposit ratio was just 65% at the end of 2008), the Chinese government was able to lean on them, as they lifted total outstanding renminbi loans by 21% in January alone. The main problem has been, of course, the disappearance of Western demand. China’s exports fell by 17.5% year on year in January, while Taiwan’s fell by 44%. But even here there was some brief respite, as evidence emerged of foreign buyers being forced to re-stock. Despite Taiwan’s announcement of a record 8.6% fall in fourth-quarter gross domestic product, its market, which is driven largely by domestic liquidity, also finished up, outperforming Hong Kong, which is more reliant on the vicissitudes of global institutional cashflow.
The ‘stimulus highlights’ in February included the Taiwanese government passing its NT$500 billion infrastructure spending program – bids will start from the end of the second quarter. Taiwan’s central bank cut the discount rate by 25 basis points to 1.25% and allowed the NT dollar to depreciate through NT$35/US$, in the wake of the Korean devaluation and apparent inflection point in the Japanese yen. In mainland China, in contrast, one official at the central bank hinted that interest rates were on hold for a while and that there is little prospect of renminbi depreciation. Following the earlier initiatives in automotives and steel, the State Council announced revitalization plans for eight industries in succession. The lucky industries were textiles, machinery, shipbuilding, electronics, petrochemical, light industry and non-ferrous metals, with logistics snatching the final place, despite heated lobbying on behalf of real estate. According to the NDRC (National Development and Reform Commission), details of the action plan will be released by mid-March and may span three years.
The success of the visit to Beijing by US Secretary of State Hillary Clinton, along with her dovish comments, has eased fears of nascent US protectionism. The state-led acquisition of overseas resources, such as Chinalco’s US$19.5 billion injection into Rio Tinto, would seem to work counter to China’s best interests in this regard.

 


 

INVESTMENT STRATEGY
The Fund is 98.1% invested, with holdings in 69 companies. The Fund’s exposure to the A-share and Taiwanese markets, both of which we expect to be supported by excess domestic liquidity, is 15.1% and 19.6%, respectively. Our exposure to direct investments is 17.8%.
During February we only made minor adjustments to the Fund. In the A-share market, we took profit on Zhangzidao and Salt Lake, but added to the baijiu producer Wuliangye. In Taiwan, we switched from capital-short Cathay Insurance into smart-phone-maker HTC. In Hong Kong, we sold China Travel, switching the money into oversold coking-coal miner Fushan.
Chris Ruffle, Martin Currie Inc*
 
*   Martin Currie Ltd and Heartland Capital Management Ltd (HCML) have established MC China Ltd (MCCL), as a joint venture company, to provide investment management or investment advisory services to the range of China investment products managed by Martin Currie.
MCCL has appointed Martin Currie Investment Management Ltd (MCIM), or its affiliates, as investment manager of Martin Currie’s China investment products. HCML has seconded both Chris Ruffle and Shifeng Ke to MCIM, or its affiliates, on a full time basis with the same roles and responsibilities as if they were full time employees.

 


 

28 FEBRUARY 2009
FUND DETAILS
         
Market cap
    US$328.06  
Shares outstanding
    22,781,762  
Exchange listed
  NYSE  
Listing date
  July 10, 1992  
Listed and direct investment manager
  Martin Currie Inc  
     
Source:   State Street Bank and Trust Company.
SECTOR ALLOCATION
                 
    The China     MSCI Golden  
    Fund, Inc     Dragon  
Consumer discretionary
    24.7 %     4.4 %
Consumer staples
    22.0 %     2.5 %
Industrials
    12.4 %     8.2 %
Healthcare
    11.3 %      
Information technology
    8.8 %     18.4 %
Financials
    6.2 %     32.7 %
Materials
    5.3 %     6.2 %
Energy
    4.9 %     8.6 %
Utilities
    1.5 %     6.4 %
Telecommunications
    1.0 %     12.7 %
Other assets & liabilities
    1.9 %      
     
Source:   State Street Bank and Trust Company. Source for index data: MSCI
ASSET ALLOCATION
(PIE CHART)
     
Source:   State Street Bank and Trust Company
         
PERFORMANCE   (US$ RETURNS)
                 
    NAV     Market price  
    %     %  
One month
    (1.4 )     (1.7 )
Year to date
    (7.1 )     (12.9 )
Three years %pa
    8.2       0.4  
     
Past performance is not a guide to future returns.
Three year returns are annualised.
 
Source:   State Street Bank and Trust Company
15 LARGEST HOLDINGS (45.7%)
             
Queenbury Investment (Huiyan)
  Consumer discretionary     10.5 %
China Huiyuan Juice
  Consumer staples     4.4 %
Shandong Weigao Group
  Healthcare     4.2 %
Chaoda Modern Agriculture
  Consumer staples     3.4 %
Wumart Stores
  Consumer staples     2.9 %
Daqin Railway
  Industrials     2.7 %
Yuanta Financial
  Financials     2.6 %
Shenzhen Agricultural Products
  Consumer staples     2.3 %
Far Eastern Department Stores
  Consumer discretionary     2.0 %
Qingdao Bright Moon
  Industrials     1.9 %
China Silicon
  Information technology     1.8 %
Uni-President Enterprises
  Consumer staples     1.8 %
Synnex Technology International
  Consumer discretionary     1.8 %
China Medical
  Healthcare     1.7 %
Taiwan Secom
  Information technology     1.7 %
DIRECT INVESTMENTS (17.8%)
             
Queenbury Investment (Huiyan)
  Consumer discretionary     10.5 %
Qingdao Bright Moon
  Industrials     1.9 %
China Silicon (Series A Preferred)
  Information technology     1.8 %
Highlight Tech
  Industrials     1.6 %
Wuxi Paiho
  Industrials     1.0 %
HAND Enterprise Solutions
  Information technology     0.8 %
China Silicon
  Information technology     0.2 %
TECO Optronics
  Information technology     0.0 %
     
Source:   State Street Bank and Trust Company.
         
FUND PERFORMANCE (BASED ON NET ASSET VALUE)   (US$ RETURNS)
                                                         
    One     Three     Calendar     One     Three     Five     Since  
    month     months     year to date     year     years     years     launch  
    %     %     %     %     % pa     % pa     % pa  
The China Fund, Inc.
    (1.4 )     1.7       (7.1 )     (46.5 )     8.2       7.4       8.7  
MSCI Golden Dragon
    (1.6 )     (1.6 )     (8.3 )     (49.1 )     (5.8 )     0.2       3.5  
Hang Seng China Enterprise
    (3.2 )     (4.3 )     (12.6 )     (50.3 )     2.0       6.3       15.4  
Shanghai Stock Exchange 180
    4.4       17.2       17.1       (52.0 )     31.7       12.9       n/a  
     
Past performance is not a guide to future returns.
 
Source:   State Street Bank and Trust Company. Launch date 10 July 1992. Three year, five year and since launch returns are all annualised.
 
Source for index data: MSCI for the MSCI Golden Dragon and Copyright 2009 Bloomberg LP for the Hang Seng China Enterprise and the Shanghai Stock Exchange 180. For a full description of each index please see the index descriptions section.

 


 

PERFORMANCE IN PERSPECTIVE
(PERFORMANCE GRAPH)
     
Past performance is not a guide to future returns.
 
Source:   Martin Currie Inc as at 28 February 2009.
THE CHINA FUND INC. PREMIUM/DISCOUNT
(PERFORMANCE GRAPH)
     
Past performance is not a guide to future returns.
 
Source:   Martin Currie Inc as at 28 February 2009.
10 YEAR DIVIDEND HISTORY CHART
(BAR GRAPH)
     
Past performance is not a guide to future returns.
 
Source:   State Street Bank and Trust Company.

 


 

28 FEBRUARY 2009
                                         
Sector   Company (BBG ticker)   Price   Holding     Value US$     % of portfolio
Hong Kong
                                    25.8 %
China Huiyuan Juice
    1886 HK     HK$ 9.0     14,059,500       16,316,108       4.4 %
Chaoda Modern Agriculture
    682 HK     HK$ 4.5     21,459,357       12,451,837       3.4 %
China Shineway Pharmaceutical
    2877 HK     HK$ 4.4     11,184,000       6,316,485       1.7 %
Xinao Gas
    2688 HK     HK$ 8.3     5,084,000       5,441,114       1.5 %
Anta Sports
    2020 HK     HK$ 3.6     11,072,000       5,139,641       1.4 %
Shangri-La Asia
    0069 HK     HK$ 8.4     4,755,555       5,120,259       1.4 %
Natural Beauty Bio-Technology
    157 HK     HK$ 1.2     32,780,000       4,945,373       1.3 %
Ports Design
    589 HK     HK$ 8.0     3,933,500       4,057,638       1.1 %
Huabao International
    336 HK     HK$ 5.6     5,500,000       3,992,779       1.1 %
Golden Meditech
    8180 HK     HK$ 0.9     35,040,000       3,840,495       1.0 %
Sina Corp
    SINA US     US$ 21.5     162,700       3,493,169       1.0 %
FU JI Food & Catering Services
    1175 HK     HK$ 3.0     8,689,000       3,350,003       0.9 %
TPV Technology
    903 HK     HK$ 2.0     12,728,000       3,331,658       0.9 %
Sinofert
    297 HK     HK$ 3.6     7,216,000       3,303,156       0.9 %
Intime Department Store Group
    1833 HK     HK$ 1.9     12,568,629       3,046,842       0.8 %
Fushan International Energy
    639 HK     HK$ 1.8     12,544,000       2,943,822       0.8 %
Honghua Group
    196 HK     HK$ 1.0     21,902,000       2,795,910       0.8 %
Yorkey Optical International
    2788 HK     HK$ 0.9     16,424,000       1,863,656       0.5 %
Chinasoft International
    8216 HK     HK$ 0.5     19,230,000       1,289,398       0.4 %
SPG Land
    1688 HK     HK$ 0.8     11,037,000       1,166,995       0.3 %
China Rare Earth
    769 HK     HK$ 0.7     9,144,000       860,723       0.2 %
 
                                       
Singapore
                                    4.2 %
China Fishery Group
    CFG SP     SG$ 0.6     12,050,000       4,635,364       1.3 %
Hsu Fu Chi International
    HFCI SP     SG$ 0.9     9,484,000       4,598,675       1.2 %
China Milk Products Group
    CMILK SP     SG$ 0.3     11,607,000       2,513,881       0.7 %
CDW
    CDW SP     SG$ 0.1     59,708,000       1,737,100       0.5 %
Financial One Corp
    FIN SP     SG$ 0.2     12,030,000       1,205,528       0.3 %
China Energy
    CEGY SP     SG$ 0.1     12,199,000       946,423       0.2 %
 
                                       
Hong Kong ‘H’ shares
                                    10.9 %
Shandong Weigao Group
    8199 HK     HK$ 13.1     9,004,000       15,325,463       4.2 %
Wumart Stores
    995 HK     HK$ 5.5     15,126,000       10,629,793       2.9 %
Zijin Mining
    2899 HK     HK$ 4.2     10,408,000       5,596,384       1.5 %
China Oilfield Services
    2883 HK     HK$ 5.5     6,388,000       4,546,824       1.3 %
ZTE Corp
    763 HK     HK$ 25.8     1,124,559       3,733,909       1.0 %
Sichuan Expressway
    107 HK     HK$ 1.3     742,000       125,337       0.0 %
 
                                       
Taiwan
                                    19.6 %
Yuanta Financial
    2885 TT     NT$ 12.8     26,635,545       9,721,976       2.6 %
Far Eastern Department Stores
    2903 TT     NT$ 13.8     18,511,584       7,286,669       2.0 %
Uni-President Enterprises
    1216 TT     NT$ 26.1     8,728,581       6,521,792       1.8 %
Synnex Technology
    2347 TT     NT$ 40.2     5,631,855       6,481,273       1.8 %
Taiwan Secom
    9917 TT     NT$ 47.0     4,738,000       6,374,934       1.7 %
Ruentex Development
    9945 TT     NT$ 17.5     12,694,000       6,359,446       1.7 %
FamilyMart
    5903 TT     NT$ 49.0     3,777,652       5,299,084       1.5 %
Lien Hwa Industrial
    1229 TT     NT$ 11.5     15,919,692       5,241,013       1.4 %
HTC Corp
    2498 TT     NT$ 385.0     438,000       4,827,448       1.3 %
China Metal Products
    1532 TT     NT$ 17.5     9,019,881       4,518,784       1.2 %
Cyberlink
    5203 TT     NT$ 119.0     1,183,000       4,030,087       1.1 %
Merry Electronics
    2439 TT     NT$ 27.2     3,584,340       2,785,876       0.8 %
Wah Lee Industrial
    3010 TT     NT$ 22.3     4,118,821       2,629,424       0.7 %
 
                                       
United Kingdom
                                    1.7 %
China Medical System Holdings
    CMSH LN     £ 1.2     3,623,188       6,385,534       1.7 %
 
                                       
United States
                                    3.0 %
The9
    CMED US     US$ 11.7     356,200       4,156,854       1.1 %
Mindray Medical International
    MR US     US$ 18.3     191,700       3,498,525       1.0 %
Far East Energy
    FEEC US     US$ 0.2     10,478,634       1,886,154       0.5 %
WuXi PharmaTech Cayman
    WX US     US$ 4.4     310,190       1,371,040       0.4 %
 
                                       
Equity linked securities (‘A’ shares)
                                    15.2 %
Daqin Railway
            US$ 1.2     8,307,000       10,019,704       2.7 %
Shenzhen Agricultural
            US$ 2.2     4,000,000       8,625,984       2.3 %
Shanghai Zhenhua Port Machinery
            US$ 1.4     4,462,752       6,028,807       1.7 %
Qinghai Salt Lake Potash
            US$ 7.2     768,509       5,503,315       1.5 %
Dalian Zhangzidao Fishery
            US$ 2.7     1,779,700       4,776,715       1.3 %
China Yangtze Power
            US$ 1.2     4,169,077       4,900,637       1.3 %
Wuliangye Yibin
            US$ 2.2     2,146,007       4,704,047       1.3 %
Zhejiang Guyuelongshan
            US$ 1.2     3,582,000       4,257,676       1.2 %
Suning Appliance
            US$ 2.4     1,599,909       3,767,786       1.0 %
Shanghai International Airport
            US$ 1.8     1,816,700       3,337,278       0.9 %

 


 

                                         
Sector   Company (BBG ticker)   Price   Holding     Value US$   % of portfolio
Direct
                                    17.7 %
Queenbury Investment (Huiyan)
            US$ 85,466.7     450       38,459,700       10.5 %
Qingdao Bright Moon
            US$ 0.2     31,827,172       7,001,978       1.9 %
China Silicon (Series A Preferred)
            US$ 238.0     27,418       6,525,484       1.8 %
Highlight Tech
            US$ 1.8     3,366,893       5,993,070       1.6 %
Wuxi Paiho
            US$ 0.3     11,734,701       3,679,990       1.0 %
HAND Enterprise Solutions
            US$ 6.1     500,000       3,050,000       0.8 %
China Silicon
            US$ 2.4     238,232       566,992       0.1 %
teco Optronics
                  1,861,710              
 
                                       
Other assets & liabilities
                            6,779,001       1.9 %
INDEX DESCRIPTIONS
MSCI Golden Dragon Index
The MSCI Golden Dragon is a free float-adjusted market capitalisation index that is designed to measure equity market performance in the China region. As of May 2005 the MSCI Golden Dragon Index consisted of the following country indices: China, Hong Kong and Taiwan.
Hang Seng China Enterprise Index
The Hang Seng China Enterprise Index is a capitalisation-weighted index comprised of state-owned Chinese companies (H-shares) listed on the Hong Kong Stock Exchange and included in Hans Seng Mainland China index.
Shanghai Stock Exchange 180 Index
The Shanghai Stock Exchange 180 ‘A’ Share Index is a capitalisation-weighted index. The index tracks the daily price performance of the 180 most representative ‘A’ share stocks listed on the Shanghai Stock Exchange.
OBJECTIVE
The investment objective of the Fund is to achieve long term capital appreciation. The Fund seeks to achieve its objective through investment in the equity securities of companies and other entities with significant assets, investments, production activities, trading or other business interests in China or which derive a significant part of their revenue from China.
The Board of Directors of the Fund has adopted an operating policy of the Fund, effective 30 June 2001, that the Fund will invest at least 80% of its assets in China companies. For this purpose, “China companies” are (i) companies for which the principal securities trading market is in China; (ii) companies for which the principal securities trading market is outside of China or in companies organised outside of China, that in both cases derive at least 50% of their revenues from goods or services sold or produced, or have a least 50% of their assets in China; or (iii) companies organised in China. Under the policy, China will mean the People’s Republic of China, including Hong Kong, and Taiwan. The Fund will provide its stockholders with at least 60 days’ prior notice of any change to the policy described above.
The Fund is subject to the Investment Company Act of 1940 which limits the means in which it can access the ‘A’ share market. The Fund will continue to seek the most efficient way in which to increase its ‘A’ share exposure ensuring ongoing compliance with its legal and regulatory obligations.
CONTACTS
The China Fund, Inc.
c/o State Street Bank and Trust Company
2 Avenue de Lafayette
PO Box 5049
Boston, MA 02206-5049
Tel: (1) 888 CHN-CALL (246 2255)
www.chinafundinc.com

 


 

Important information: This document is issued and approved by Martin Currie Inc (MC Inc), as investment adviser of The China Fund Inc (the Fund). MC Inc is authorised and regulated by the Financial Services Authority (FSA) and incorporated under limited liability in New York, USA. Registered in Scotland (No BR2575), registered address Saltire Court, 20 Castle Terrace, Edinburgh, EH1 2ES. Information herein is believed to be reliable but has not been verified by MC Inc. MC Inc makes no representation or warranty and does not accept any responsibility in relation to such information or for opinion or conclusion which the reader may draw from the newsletter.
Martin Currie Ltd and Heartland Capital Management Ltd (HCML) have established MC China Ltd (MCCL), as a joint venture company, to provide investment management or investment advisory services to our China product. MCCL has appointed Martin Currie Investment Management Ltd (MCIM), or its affiliates, as investment manager of our China funds. HMCL has seconded both Chris Ruffle and Shifeng Ke to MCIM or its affiliates on a full time basis with the same roles and responsibilities as if they were full time employees.
The Fund is classified as a ‘non-diversified’ investment company under the US Investment Company Act of 1940 as amended. It meets the criteria of a closed ended US mutual fund and its shares are listed on the New York Stock Exchange. MC Inc has been appointed investment adviser to the Fund.
Investors are advised that they will not generally benefit from the rules and regulations of the United Kingdom Financial Services and Markets Act 2000 and the FSA for the protection of investors, nor benefit from the United Kingdom Financial Services Compensation Scheme, nor have access to the Financial Services Ombudsman in the event of a dispute. Investors will also have no rights of cancellation under the FSA’s Conduct of Business Sourcebook of the United Kingdom.
This newsletter does not constitute an offer of shares. MC Inc, its ultimate and intermediate holding companies, subsidiaries, affiliates, clients, directors or staff may, at any time, have a position in the market referred to herein, and may buy or sell securities, currencies, or any other financial instruments in such markets. The information or opinion expressed in this newsletter should not be construed to be a recommendation to buy or sell the securities, commodities, currencies or financial instruments referred to herein.
The information provided in this report should not be considered a recommendation to purchase or sell any particular security. There is no assurance that any securities discussed herein will remain in an account’s portfolio at the time you receive this report or that securities sold have not been repurchased.
It should not be assumed that any of the securities transactions or holdings discussed here were or will prove to be profitable, or that the investment recommendations or decisions we make in the future will be profitable or will equal the investment performance of the securities discussed herein.
Investing in the Fund involves certain considerations in addition to the risks normally associated with making investments in securities. The value of the shares issued by the Fund, and the income from them, may go down as well as up and there can be no assurance that upon sale, or otherwise, investors will receive back the amount originally invested. There can be no assurance that you will receive comparable performance returns, or that investments will reflect the performance of the stock examples contained in this document. Movements in foreign exchange rates may have a separate effect, unfavorable as well as favorable, on the gain or loss otherwise experienced on an investment. Past performance is not a guide to future returns. Accordingly, the Fund is only suitable for investment by investors who are able and willing to withstand the total loss of their investment. In particular, prospective investors should consider the following risks:
®   The companies quoted on Greater Chinese stock exchanges are exposed to the risks of political, social and religious instability, expropriation of assets or nationalisation, rapid rates of inflation, high interest rates, currency depreciation and fluctuations and changes in taxation, which may affect income and the value of investments.
 
®   At present, the securities market and the regulatory framework for the securities industry in China is at an early stage of development. The China Securities Regulatory Commission (CSRC) is responsible for supervising the national securities markets and producing relevant regulations. The Investment Regulations, under which the Fund invests in the People’s Republic of China (PRC) and which regulate repatriation and currency conversion, are new. The Investment Regulations give CSRC and State Administration of Foreign Exchange (SAFE) wide discretions and there is no precedent or certainty as to how these discretions might be exercised, either now or in the future. The Fund may, from time to time, obtain access to the securities markets in China via Access Products. Such products carry additional risk and may be less liquid than the underlying securities which they represent.
 
®   During the past 15 years, the PRC government has been reforming the economic and political systems of the PRC, and these reforms are expected to continue, as evidenced by the recently announced changes. The Fund’s operations and financial results could be adversely affected by adjustments in the PRC’s state plans, political, economic and social conditions, changes in the policies of the PRC government such as changes in laws and regulations (or the interpretation thereof), measures which may be introduced to control inflation, changes in the rate or method of taxation, imposition of additional restrictions on currency conversion and the imposition of additional import restrictions.
 
®   PRC’s disclosure and regulatory standards are in many respects less stringent than standards in certain Organisation for Economic Co-operation and Development (OECD) countries, and there may be less publicly available or less reliable information about PRC companies than is regularly published by or about companies from OECD countries.
 
®   The Shanghai Stock Exchange and Shenzhen Stock Exchange have lower trading volumes than most OECD exchanges and the market capitalisations of listed companies are small compared to those on more developed exchanges in developed markets. The listed equity securities of many companies in the PRC are accordingly materially less liquid, subject to greater dealing spreads and experience materially greater volatility than those of OECD countries. These factors could negatively affect the Fund’s NAV.
 
®   The Fund invests primarily in securities denominated in other currencies but its NAV will be quoted in US dollars. Accordingly, a change in the value of such securities against US dollars will result in a corresponding change in the US dollar NAV.
 
®   The marketability of quoted shares may be limited due to foreign investment restrictions, wide dealing spreads, exchange controls, foreign ownership restrictions, the restricted opening of stock exchanges and a narrow range of investors. Trading volume may be lower than on more developed stockmarkets, and equities are less liquid. Volatility of prices can also be greater than in more developed stockmarkets. The infrastructure for clearing, settlement and registration on the primary and secondary markets may be underdeveloped. Under certain circumstances, there may be delays in settling transactions in some of the markets.
Martin Currie Inc, registered in Scotland (no BR2575)
Registered office: Saltire Court, 20 Castle Terrace, Edinburgh EH11 2ES Tel: 44 (0) 131 229 5252 Fax: 44 (0) 131 228 5959 www.martincurrie.com/china
North American office: 1350 Avenue of the Americas, Suite 3010, New York, NY 10019, USA Tel: (1) 212 258 1900 Fax: (1) 212 258 1919
Authorised and registered by the Financial Services Authority and incorporated with limited liability in New York, USA.
Please note: calls to the above numbers may be recorded.